Company attributes
B2X
Founder
Pitchbook URL
Legal Name
PhagoMed Biopharma GmbH
Parent Organization
Date Incorporated
2017
Number of Employees (Ranges)
11 – 50
Email Address
Number of Employees
14
Full Address
Leberstraße 20 1110 Vienna Austria
Founded Date
November 23, 2017
Total Funding Amount (USD)
6,400,000
Latest Funding Type
Country
Headquarters
Other attributes
Company Operating Status
Active
PhagoMed Biopharma is a biotechnology company developing phage therapies to replace ineffective antibiotics that is headquartered in Vienna, Austria and was founded in 2017 by Alexander Belcredi and Burkhard Wippermann.
Virtual tour of PhagoMed Biopharma.
Products
PM398
PM398 is a phage therapy designed to destroy multi-drug resistant methicillin-resistant Staphylococcus aureus (MRSA).
PhagoMed PM398 in action.
Funding
Seed
On August 28, 2018 PhagoMed Biopharma completed a seed funding round with €4M in funding from from undisclosed investors.
Timeline
No Timeline data yet.
